The Drug Enforcement Administration (DEA) is apparently on the verge of rescheduling cannabis, potentially within days or weeks.
The move would mark the most significant federal action toward marijuana legalization since its prohibition nearly a century ago.
Speculation swirling around the industry has resulted in a mix of optimism, jumping the gun and high-level crystal-ball gazing.
Here, however, is the view of one well-connected Adrian Snead, a partner in the Washington, D.C. office and member of the firm’s Government & Regulatory Affairs and Litigation Practice Groups. Snead also worked with SAFER Banking sponsor Sen. Jeff Merkley.
$MSOS pic.twitter.com/Vh3XOPWhdJ
— The Psychedelic Bull (@psychedelicbull) February 6, 2024
So, What Happens If It Happens? At the moment, cannabis remains on Schedule I of the Controlled Substances Act alongside heroin and LSD, signifying no accepted medical value and high potential for …
Leave a Reply